subscribeSubscribe
Merck Opens Enrollment in PIII with Islatravir in Combination with Doravirine

Merck Opens Enrollment in PIII with Islatravir in Combination with Doravirine
BUSINESSWIRE
22 Feb 2023
Share Share
FDA Confirms Paragraph IV Patent Litigation for Delstrigo (Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate)

FDA Confirms Paragraph IV Patent Litigation for Delstrigo (Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate)
FDA
03 Oct 2022
Share Share
Merck to start studying lower dose of HIV drug after FDA hold

Merck to start studying lower dose of HIV drug after FDA hold
REUTERS
21 Sep 2022
Share Share
Merck HIV combo pill compares to existing meds in phase 3 trials

Merck HIV combo pill compares to existing meds in phase 3 trials
K. LaHucik FIERCEBIOTECH
28 Oct 2021
Share Share
Merck Announces New Analyses Showing Additional Safety & Efficacy for Islatravir

Merck Announces New Analyses Showing Additional Safety & Efficacy for Islatravir
BUSINESSWIRE
06 Jul 2020
Share Share
Merck Underscores Commitment to HIV with New Data Analyses at AIDS 2020

Merck Underscores Commitment to HIV with New Data Analyses at AIDS 2020
BIOSPACE
24 Jun 2020
Share Share
FDA ends CSR pilot, plots new approach for disclosing study reports

FDA ends CSR pilot, plots new approach for disclosing study reports
Z. Brennan ENDPTS
28 Mar 2020
Share Share
Merck’s PIFELTRO™ and DELSTRIGO™ get FDA permission to treat HIV-1

Merck’s PIFELTRO™ and DELSTRIGO™ get FDA permission to treat HIV-1
BIOSPECTRUMASIA
25 Sep 2019
Share Share
Merck`s Big Week: HIV Approval and Landmark 3-Country Approval for Keytruda

Merck`s Big Week: HIV Approval and Landmark 3-Country Approval for Keytruda
Mark Terry BIOSPACE
20 Sep 2019
Share Share
FDA Action Alert: Merck and Amarin

FDA Action Alert: Merck and Amarin
Mark Terry BIOSPACE
16 Sep 2019
Share Share